Take the B-HERO-S survey and contribute to a better understanding of the psychosocial issues of living with hemophilia B.
FDA approves Octapharma’s latest therapy NUWIQ®, for people with hemophilia A. Clinical trial data showed good to excellent results overall.
BioMarin announces enrollment of the first patient in clinical trial of BMN 270, a gene therapy to treat people with hemophilia A.
January 22 is the deadline to submit research poster abstracts for the WFH 2016 World Congress in Orlando, Florida, July 24-28, 2016.
Last night on the Tonight Show Lady Gaga linked hemophilia to her vampire TV character.
The goal of this activity is to discuss the unique challenges facing nurses who treat adults with hemophilia.
NHF and IMPACT announce the CCSC, an ongoing quality improvement and cost-management initiative driven by HTC and payer/managed care professionals.
New Medscape Educational Activity for clinicians helps them identify common risks and devise optimal strategies for challenging scenarios.
Genentech receives breakthrough therapy designation from the FDA for ACE910 subcutaneous therapy for hemophilia A.
FDA approves expanded use of Octapharma's WILATE for surgery in patients with VWD.
eNewsletter Sign Up
Steps for Living
Victory for Women
Donate Your Car